Graft Polymer (GPL) Share Price, News & Analysis

Company Overview

Graft Polymer (UK) Plc is an innovative biotechnology company focused on developing intellectual property relating to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Our mission is to improve outcomes for individuals suffering from these conditions, with an initial focus on trauma-related mental health disorders, such as PTSD, which affects approximately 13 million adults in the U.S. and 20 million in US, UK, and key EU markets.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 4.15 million shs
• Average Volume: 8.69 million shs
• Market Capitalization: £3.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Industrials
• Industry: Machinery
• Sub-Industry: Industrial Machinery & Supplies & Components
• Current Symbol: LON:GPL
• CIK: N/A
• Web: www.graftpolymer.com
• Phone: 44 20 4524 9900
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX (2.49)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£58.52 million
• Net Margins: -531.52%
• Pretax Margin: N/A
• Return on Equity: -94.83%
• Return on Assets: -38.87%

Debt

• Debt-to-Equity Ratio: 1.68
• Current Ratio: 0.81
• Quick Ratio: 18.19

Sales & Book Value

• Annual Sales: £7.75 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 5.09
• Book Value: GBX 1.59 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,324,101,227
• Free Float: N/A
• Market Cap: £3.79 million
• Optionable: Not Optionable
• Beta: 1.92